pta20250131045
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR
Venlo (pta045/31.01.2025/22:10 UTC+1) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Ross Levine |
| 2 | Reason for the notification | |
| a) | Position/status | Member of the administrative or supervisory body |
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | QIAGEN N.V. |
| b) | LEI | 54930036WK3GMCN17Z57 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | NL0015002CX3 | |
| b) | Nature of the transaction | Another |
| Following the terms of the synthetic share repurchase by QIAGEN N.V., which was announced in January 2025 and approved in June 2024 at the Annual General Meeting of shareholders, every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares. The number of shares held by Mr. Levine were consolidated by 465 shares into 16,273. common shares. | ||
| c) | Price(s) | Volume(s) |
| Not Quantifiable | Not Quantifiable | |
| d) | Aggregated price | Aggregated volume |
| Not Quantifiable | Not Quantifiable | |
| e) | Date of the transaction | 28.01.2025 UTC+1 |
| f) | Place of the transaction | Outside a trading venue |
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0015002CX3 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |